-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Olema Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q3 2024.
- Olema Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $3.07M, a 66.6% increase year-over-year.
- Olema Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $13.2M, a 132% increase year-over-year.
- Olema Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $8.31M, a 277% increase from 2022.
- Olema Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $2.2M, a 457% increase from 2021.
- Olema Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $395K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)